Buscar
Mostrando ítems 11-20 de 163
Acquired aplastic anemia. Experience in a public hospital Aplasia medular adquirida, experiencia en un hospital público de referencia
(Sociedad Medica de Santiago, 2018)
© 2018, Sociedad Medica de Santiago. All Rights reserved. Background: The first line treatment for patients < 40 years old with aplastic anemia (AA) is allogeneic HLA-identical sibling donor transplantation (SCT). ...
Acquired hemoglobin H disease in a patient with aplastic anemia evolving into acute myeloid leukemia
(Associação Paulista de Medicina - APM, 2004-12-01)
CONTEXT: The prognosis of severe aplastic anemia has improved since the introduction of bone marrow transplantation and treatment with antithymocyte globulin. In contrast to the success of these protocols, studies with ...
Aplasia medular adquirida y embarazo. Caso clínico
(Sociedad Médica de Santiago, 2018)
Aplastic anemia (AA) or acquired aplastic anemia is an uncommon and potentially fatal disease. It is defined as reduction of at least two peripheral blood series, associated with persistent bone marrow hypocellularity. ...
Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders
(W B Saunders Co LtdLondonInglaterra, 2001)
Anemia aplástica adquirida del adulto: Su tratamiento a propósito de dos casos
(Sociedad Médica de Santiago, 2003)
Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population
(Taylor & Francis Ltd, 2015-06-24)
The impaired hematopoiesis in acquired aplastic anemia (AA) results from immune-mediated mechanisms. We characterized polymorphisms implicated in controlling type-1 cytokine production in 69 patients with AA. Our data ...
A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
(Associação Brasileira de Divulgação Científica, 2009-03-01)
Allogeneic hematopoietic stem cell transplantation (AHSCT) is the treatment of choice for young patients with severe aplastic anemia (SAA). The association of antithymocyte globulin (ATG) and cyclophosphamide (CY) is the ...
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
(Nature Publishing GroupLondonInglaterra, 2004)